The Heart Institute at Cincinnati Children’s is one of the most productive pediatric academic medical centers for cardiomyopathy research in the country, as evidenced by our dollars received and papers published.

In fiscal year 2014, we published over 50 cardiomyopathy-related articles in peer-reviewed journals.

Additionally, our experts are world-renowned leaders in the field and have written the standards of care and treatment for cardiomyopathy patients.

We don’t just diagnose and treat cardiomyopathy, we conduct research locally, nationally and internationally into the causes and treatments of this disease, ensuring bench-to-beside application as quickly as possible.

Recently, we established a new standard of care based on research findings that 39 percent of children who undergo heart transplants often develop coronary artery disease due to viral infections after surgery. As a result, on follow-up, we now biopsy myocardium from all transplant patients for viral PCR testing through our Heart Institute Diagnostic Laboratory.

If the biopsy shows the child has a viral infection, we treat with intravenous immunoglobulin, which boosts the child’s immune system’s ability to fight off infection.

The Heart Institute has been integral in the advancement of the genetic causes of cardiomyopathy and interventions in treatment. Our research has lead to significant findings in cardiomyopathy and our grant funding totals more than $16.9 million.